Search

Learn the truth behind common misunderstandings about breast reconstruction.

… Thursday, October 4, 2018 Summary Breast reconstruction after surgery often improves quality of life. Yet many women choose not to have the procedure because of persistent myths about its benefits and risks. People thinking about breast reconstruction should talk to their doctor about the options. Women

New research from the Craig Thompson Lab offers a closer look at the transcriptional activators, Yap/Taz, and the role they play in cell growth and macropinocytosis.

… Wednesday, September 30, 2020 New research from the Craig Thompson Lab offers a closer look at the transcriptional activators, Yap/Taz, and the role they play in cell growth and macropinocytosis. (Also known as “cell drinking,” macropinocytosis is a process through which single-celled, amoeboid organisms

Learn from gynecologic surgeon Vance Broach about cervical cancer prevention, diagnosis, and treatment.

… Wednesday, January 10, 2018 Update: On October 5, 2018, the US Food and Drug Administration announced that it had expanded the approved use of the Gardasil 9 vaccine to include women and men aged 27 through 45 years. “Today’s approval represents an important opportunity to help prevent HPV-related diseases

Treating pituitary tumors with combination immunotherapy may be an effective treatment strategy, especially for tumors that are resistant to temozolomide.

… Friday, February 8, 2019 Our results suggest that clinical sequencing of pituitary tumors that have relapsed after treatment with traditional chemotherapy can identify mutations that may respond to immunotherapy. Andrew Lin Associate Attending Neurologist The response of patients with pituitary tumors

… Tuesday, March 10, 2026 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Luis Díaz Jr. Received the 2026 Gustave Roussy Award Luis Díaz Jr. Luis Díaz Jr., MD,   Gastrointestinal Medical Oncologist, received the 2026 Gustave Roussy Prize , which honors

Learn how MSK's researchers are making important strides in overcoming breast cancer resistance.

… Thursday, October 16, 2025 Figuring out how to outsmart breast cancer — preventing it from spreading or coming back after treatment — is a relentless challenge for oncologists. Now researchers at Memorial Sloan Kettering Cancer Center (MSK) have embarked on a bold new effort to predict ahead of time

A study presented at the 2017 annual meeting of the American Society of Clinical Oncology showed that an online tool to monitor patients’ symptoms improved overall survival.

… Sunday, June 4, 2017 Summary A new analysis showed that overall survival was improved for people who monitored their symptoms using an online tool. People receiving chemotherapy for metastatic solid tumors survived longer when they used a web-based tool to document their symptoms, according to results

Three young investigators who have taken significant steps toward advancing the understanding of cancer will be the recipients of this year's Paul Marks Prize for Cancer Research, a prize awarded biennially since 2001 to scientists under the age of forty-six by Memorial Sloan Kettering Cancer Center.

… Tuesday, September 29, 2009 Three young investigators who have taken significant steps toward advancing the understanding of cancer will be the recipients of the 2009 Paul Marks Prize for Cancer Research, a prize awarded biennially since 2001 to scientists under the age of forty-six by Memorial Sloan

New data reveals that women treated with radiation to the chest for childhood cancer have a high risk of developing breast cancer similar to that of women with BRCA1/2 mutations. The study, led by Memorial Sloan Kettering Cancer Center biostatistician Chaya Moskowitz, PhD, was presented today at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.

… Monday, June 4, 2012 New data reveals that women treated with radiation to the chest for childhood cancer have a high risk of developing breast cancer similar to that of women with BRCA1/2 mutations. The study, led by Memorial Sloan Kettering Cancer Center biostatistician Chaya Moskowitz, PhD , was presented

Learn more about the work of MSK lymphoma researchers being presented at the 2019 meeting of the American Society of Hematology.

… Sunday, December 8, 2019 Summary MSK researchers report advances in the treatment of various types of lymphoma at the annual meeting of the American Society of Hematology. The American Society of Hematology (ASH) annual meeting is the world’s premier event devoted to the study of blood cancers and disorders